*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI ≥30, or BMI ≥27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone).
Lose weight up to
On average, people on semaglutide lose 15-20% of their weight in a year
Disclaimer: Results may vary. Individual experiences and outcomes depend on personal factors, program participation, and lifestyle choices.
Weight management can look very different depending on lifestyle, schedule, and health history. That’s why InjectCo starts every California patient’s experience with an online evaluation to gather the right context before making recommendations. Many adults across California are seeking medically guided programs that offer professional oversight without requiring frequent in-person visits.
InjectCo’s medical weight loss program is built around individual needs rather than a preset formula. During the evaluation, a licensed provider reviews relevant information and determines whether compounded medication may be incorporated as part of a broader program that also considers nutrition habits, consistency, and long-term support.
Compounded GLP-1–based treatment plans may be included within physician-guided weight loss programs for California patients who benefit from additional structure and medical oversight. Semaglutide is one option in this category and may be considered depending on individual factors identified during the evaluation process.
At InjectCo, compounded semaglutide is not offered independently. When included, it is part of a comprehensive medical weight loss program that involves provider oversight, follow-up check-ins, and adjustments based on how the patient responds over time.
For some California patients, licensed providers may consider a medical weight loss program that incorporates compounded GLP-1 + GIP–based treatment plans. Tirzepatide is one option that may be evaluated as part of a structured, physician-guided approach, depending on health history and program goals.
When incorporated, compounded tirzepatide is supported through ongoing online care and provider monitoring. Treatment plans may be refined over time to align with patient needs, helping ensure the program remains appropriate and well-supported.
Many California patients explore medically assisted weight loss after traditional approaches haven’t delivered the progress they hoped for. While eligibility can only be determined by a licensed provider, there are common factors that may indicate whether someone could be a good fit for a physician-guided weight loss program that may incorporate compounded GLP-1 or GLP-1/GIP–based medications.
You may be a potential candidate if you:
Your monthly program includes:
We understand that starting a medical weight loss program is an investment, which is why InjectCo offers financing options through Cherry and CareCredit. You can begin your program right away and pay over time with simple monthly plans.
years
Kiara founded InjectCo in 2021 with a vision to combine ethics, education, and artistry in aesthetics. She leads eight clinics across Texas and established the Texas Academy of Medical Aesthetics to train future injectors. Her focus remains on safe, natural results and meaningful patient relationships.
years
Jen, a registered nurse for over 13 years, specializes in advanced aesthetic and Botox techniques. Cadaver-certified and highly sought after, she’s known for ultra-natural results. Jen prioritizes safety, patient education, and industry growth, training other injectors weekly to advance skills and standards.
years
Shelby blends aesthetic expertise with a holistic approach, believing confidence and wellness go hand in hand. She creates customized treatment plans that combine injectables with advanced technologies. Passionate about enhancing natural beauty, Shelby helps patients look and feel their best, making her essential to InjectCo.
Progress varies based on individual factors, lifestyle habits, and program participation. Some patients notice early changes over time, while others experience more gradual progress with continued provider guidance. Results may vary.
When prescribed, optional delivery through a licensed 503B pharmacy may be available for eligible California patients. Delivery is coordinated discreetly and does not require pharmacy pickup.
Yes, patients throughout California, including both urban and rural areas, may access the online evaluation process. Participation depends on provider review and medical appropriateness.
The monthly program fee includes online medical evaluation, provider oversight, and ongoing support. When appropriate, compounded medications may be incorporated into the program, along with continued monitoring and adjustments over time.
Yes, provider oversight continues throughout the program. Patients have access to follow-up care, progress monitoring, and guidance as they move forward.
Ready to start working with medical professionals who understand weight management? InjectCo’s physician-guided weight loss program gives California patients access to online evaluation, personalized care, and ongoing support without the hassle of in-person visits. When appropriate, compounded medications may be incorporated as part of a broader plan designed to support steady, sustainable progress.
Start your online evaluation today and take the first step toward a more supportive approach to weight-loss goals.
